Valerie Start
Fortuna: 282 480 $ al 31/05/2026
Fortuna: 282 480 $ al 31/05/2026
Valerie Denise Harding Start is currently an Independent Director at Erasca, Inc. since 2019, a Member & Partner at Smallify LLC, and Principal at Start Pharma Consulting LLC since 2019.
Formerly, Dr. Start was Vice President-Product Differentiation at Pfizer Inc. in 2012 and Senior VP-Chemistry, Manufacturing & Controls at Ignyta, Inc. from 2015 to 2019.
Dr. Start completed undergraduate studies at the University of London and earned a doctorate from The University of Nottingham.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ERASCA, INC. 0,01 % | 26/06/2026 | 22.000 ( 0,01 % ) | 282 480 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ERASCA, INC. | Director/Miembro de la Junta | 01/06/2019 |
Start Pharma Consulting LLC | Corporate Officer/Principal | 01/02/2019 |
Smallify LLC
Smallify LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting, training, certification and tools to embed rapid innovation practices inside an organization | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| IGNYTA INC | Corporate Officer/Principal | 01/01/2019 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2012 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nottingham
The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ignyta, Inc.
Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Erasca, Inc.
Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
Smallify LLC
Smallify LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting, training, certification and tools to embed rapid innovation practices inside an organization | Commercial Services |
Start Pharma Consulting LLC |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.